Company Filing History:
Years Active: 2021-2025
Title: David Piper: Innovator in Microfluidic Technology
Introduction
David Piper, an inventive mind based in Leominster, MA, has made significant strides in the field of microfluidic technology. With a focus on medication administration, his innovations aim to enhance the precision and efficiency of drug delivery systems. Over the course of his career, he has been granted two patents that showcase his commitment to improving medical technology.
Latest Patents
David Piper's most recent patents include "Devices and methods for providing a bolus dose in a microfluidic circuit of a pump" and "Devices and methods for administering a medication in fluid form." These patents detail systems and methods that utilize a basal flow path and a bolus flow path working in parallel to effectively administer medication. A key feature of these inventions is the combined piston pump and rotatable valve designed to prevent partial dosing of a bolus dose. Additionally, the bolus flow path includes an inlet check valve, a first outlet check valve downstream of the inlet check valve, and a piston pump positioned between the inlet and outlet check valves, ensuring precise delivery of the medication.
Career Highlights
Throughout his career, David has demonstrated a strong aptitude for innovation, particularly within the realm of medical devices. His work at Cequr SA has allowed him to contribute directly to advancements in the delivery of medication, impacting patient care and treatment outcomes.
Collaborations
David collaborates with talented individuals such as Hermanus Stephanus Pretorius and Robert Farra, collectively pushing the boundaries of what is possible in medical technology. Their shared expertise and vision foster a collaborative environment that drives innovation at Cequr SA.
Conclusion
David Piper’s contributions to microfluidic technology exemplify the power of innovation in healthcare. His patented inventions pave the way for more effective medication delivery, ultimately enhancing patient experiences. As he continues to work alongside his colleagues, the future of drug administration appears promising.